Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q2
добавлен 12.08.2024
Citius Pharmaceuticals Мультипликаторы 2011-2024 | CTXR
Мультипликаторы по годам Citius Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.6 | -4.9 | -4.7 | -2.2 | -0.7 | -1.3 | -1.7 | -4.2 | -13.9 | - | - | - | - |
P/S |
- | - | 1206.7 | - | - | - | - | - | - | - | - | - | - |
EPS |
-0.2 | -0.2 | -0.2 | -0.5 | -0.8 | -1.2 | -1.9 | -2.3 | -1.4 | -0.0 | - | - | - |
EV (Enterprise Value) |
102 млн | 132 млн | 48.2 млн | 34.7 млн | 7.8 млн | 9.78 млн | 16.9 млн | 39.7 млн | 41.1 млн | 32.6 млн | -39.7 тыс. | 4.33 тыс. | 23.8 тыс. |
EBITDA per Share |
-0.24 | -0.23 | -0.22 | -0.444 | -0.774 | -1.28 | -1.82 | -2.06 | -1.52 | - | - | - | - |
EV/EBITDA |
-2.0 | -1.4 | -0.2 | -0.5 | -1.5 | -4.7 | -12.3 | - | - | - | - | ||
PEG |
0.14 | 0.15 | 0.14 | -0.05 | -0.02 | -0.03 | -0.11 | 0.06 | 1.9 | - | - | - | - |
P/B |
1.3 | 1.6 | 0.8 | 1.1 | 0.5 | 0.6 | 0.8 | 2.1 | -63.6 | -42.9 | - | - | - |
P/CF |
-4.0 | -5.8 | -4.5 | -2.3 | -0.9 | -1.4 | -2.2 | -5.9 | -16.9 | -176.9 | - | - | - |
ROE % |
-35.83 | -32.72 | -17.44 | -52.12 | -63.84 | -44.99 | -47.32 | -49.48 | 456.90 | - | - | - | - |
ROA % |
-31.41 | -29.51 | -16.19 | -40.09 | -53.69 | -40.37 | -42.53 | -37.79 | -391.38 | - | - | - | - |
ROCE % |
-40.44 | -32.40 | -17.80 | -44.64 | -63.98 | -49.48 | -45.50 | -44.43 | 508.48 | - | - | - | - |
Current Ratio |
8.5 | 10.8 | 14.8 | 3.4 | 1.7 | 3.2 | 1.4 | 0.2 | 0.5 | 0.7 | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Citius Pharmaceuticals
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.06 | -0.05 | -0.06 | - | -0.06 | -0.07 | -0.02 | -0.18 | -0.06 | -0.05 | -0.06 | -0.2 | -0.05 | -0.04 | -0.15 | -0.38 | -0.11 | -0.15 | -0.15 | -0.61 | -0.2 | -0.15 | -0.22 | -0.99 | -0.19 | -0.22 | -0.38 | -1.47 | -0.48 | -0.38 | -0.44 | - | -0.75 | -0.03 | -0.04 | -0.06 | -0.03 | -0.04 | -0.03 | -0.04 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.06 | - | - | - | -0.05 | -0.18 | -0.06 | -0.05 | -0.06 | -0.19 | -0.04 | -0.04 | -0.15 | -0.39 | -0.11 | -0.15 | -0.15 | -0.62 | -0.2 | -0.15 | -0.22 | -1.04 | -0.19 | -0.22 | -0.38 | -1.52 | -0.45 | -0.38 | -0.57 | - | -0.44 | -0.04 | -0.04 | -0.07 | -0.02 | -0.04 | -0.03 | -0.03 | - | -0.05 | -0.03 | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-8659.96 | -17273.58 | -17274.28 | -8640.98 | -8665.93 | -48.00 | -42.93 | -46.78 | -35.52 | -31.73 | -28.61 | -52.78 | -78.98 | -88.63 | -117.66 | -104.75 | -108.75 | -116.47 | -105.37 | -101.08 | -97.29 | -84.03 | -78.84 | -77.02 | -70.39 | -73.07 | -69.60 | -71.39 | -59.51 | -70.04 | -70.46 | 42.22 | 356.12 | 507.56 | 712.72 | 735.97 | 510.97 | 385.79 | 304.64 | 223.04 | 347.62 | 556.40 | 447.81 | 429.48 | 263.99 | 98.51 | 99.09 | 99.24 | 161.73 | 224.22 | 230.94 | 110.49 | 110.49 | 9.72 |
ROA % |
-37.47 | -34.26 | -34.94 | -21.00 | -43.50 | -43.18 | -39.00 | -42.49 | -32.70 | -29.30 | -26.28 | -42.64 | -60.61 | -67.33 | -83.05 | -77.28 | -79.02 | -83.53 | -79.83 | -76.33 | -75.12 | -66.43 | -64.00 | -61.60 | -60.46 | -63.87 | -64.69 | -63.41 | -49.82 | -56.37 | -52.99 | -378.29 | -647.18 | -741.96 | -896.67 | -644.90 | -418.35 | -309.34 | -197.61 | -592.46 | -550.12 | -554.01 | -507.26 | -1446.61 | -17741.22 | -34041.96 | -35087.68 | -34842.22 | -30966.48 | -27090.74 | -27250.21 | -12425.00 | -12425.00 | -1211.32 |
ROCE % |
-8859.33 | -17668.99 | -17666.81 | -8840.89 | -8865.95 | -51.95 | -46.74 | -47.00 | -35.80 | -32.08 | -28.99 | -53.17 | -79.60 | -89.17 | -118.18 | -105.78 | -109.46 | -117.26 | -106.74 | -101.90 | -99.81 | -86.43 | -80.62 | -78.79 | -71.46 | -73.39 | -69.91 | -75.74 | -53.87 | -56.27 | -60.34 | 48.98 | 405.01 | 539.50 | 752.05 | 780.50 | 498.65 | 377.02 | 299.53 | 210.01 | 227.09 | 250.30 | 133.82 | 116.65 | 58.29 | 48.38 | 47.75 | 47.92 | 112.33 | 128.61 | 135.58 | 97.29 | 29.76 | 8.32 |
Current Ratio |
9.0 | 8.4 | 8.1 | 8.5 | 9.1 | 8.4 | 10.5 | 10.8 | 12.1 | 13.3 | 10.6 | 14.8 | 15.7 | 14.8 | 3.7 | 4.3 | 4.3 | 4.3 | 5.4 | 3.8 | 6.3 | 6.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.7 | - | - | 0.0 | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD